HK Stock Market Move | BAYZED HEALTH (02609) fell by more than 21% last week, welcoming the final wave of lifting of restrictions. There have been two large amount deposits in recent times.

date
11:40 30/06/2026
avatar
GMT Eight
Baize Medical (02609) fell more than 21%, as of the time of publication, dropping 21.05% to HK$4.05, with a turnover of HK$61.0881 million.
BAYZED HEALTH (02609) fell more than 21% as at the time of writing, dropping by 21.05% to HK$4.05, with a trading volume of HK$61.08 million. On the news front, BAYZED HEALTH saw the last batch of lock-up shares released on June 24. The company's controlling shareholder, Xu Xu, saw the second batch of restricted shares released, with 396 million shares unlocked, accounting for 30% of the total share capital. In addition, on June 11 and June 12, BAYZED HEALTH saw two large deposits. On June 11, there was a position change with the company's shareholder depositing 295 million shares with CITIC SEC Brokerage in Hong Kong, holding a 22.39% stake; on June 12, another position change occurred with the shareholder depositing 684 million shares with Futu Securities International in Hong Kong, holding a 51.86% stake. Financial data for Bayzed Medical in 2025 showed revenue of RMB 1.12 billion, a 5.8% decrease year-on-year; equity attributable to shareholders a loss of RMB 12.957 million, a 3.7% decrease. During the period, revenue decreased by approximately 5.8%, mainly due to a decrease in hospital business revenue by RMB 37.4 million; and a decrease in revenue from supplying drugs, medical equipment, and consumables by RMB 21.6 million.